June 23, 2025

Teen ACL Injuries Linked to High Reinjury Risk

A long-term study of adolescent athletes who underwent ACL reconstruction found high rates of reinjury and other knee damage but also noted that most returned to sports and reported improved knee function over time.

Conexiant

June 06, 2025

ADHD, Age, and Sex Affect Concussion Recovery: Study

Athletes with ADHD took longer to return to school and sports after concussion, with researchers reporting they needed 1.16 to 1.17 times more recovery time than peers.

Conexiant

June 06, 2025

New Global Criteria Define Pediatric Bone Disease

An international team developed and validated the first global classification criteria for pediatric chronic nonbacterial osteomyelitis, offering a standardized tool to improve research and diagnosis.

Conexiant

April 01, 2025

FDA Approves Freeze-Dried Jynneos Vaccine

Bavarian Nordic’s freeze-dried Jynneos vaccine offers logistical advantages over the liquid-frozen version, supporting long-term U.S. stockpiling and public health preparedness.

Conexiant

April 29, 2025

Foley Catheter Management: New Best Practices, Pitfalls

Foley catheter use is associated with a wide range of complications, from infections to urethral erosion.

Conexiant

May 28, 2025

Kennedy Proposes NIH Publishing Ban

"We're probably going to stop publishing in The Lancet, New England Journal of Medicine, JAMA, and those other journals because they're all corrupt."

Conexiant

April 23, 2025

Sense of Belonging 'Critical' for Workplace Retention

Individuals who reported a neutral level of satisfaction with their sense of belonging were approximately 3 times more likely to express an intent to leave, while those who were dissatisfied were 7 times more likely to do so, compared to individuals who were satisfied with their sense of belonging.

Conexiant

April 02, 2025

FDA Misses Novavax Decision Date

FDA misses April 1 deadline for deciding on Novavax's COVID-19 vaccine.

Reuters

April 02, 2025

FDA Approves Automated Latent TB Test

Revvity’s Auto-Pure 2400 platform for use with the T-SPOT.TB test to automate latent tuberculosis diagnostics was approved by the FDA.

Conexiant